BioInvent International AB - Company Profile
Powered by 
All the sales intelligence you need on BioInvent International AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BioInvent International AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BioInvent International AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on BioInvent International AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into BioInvent International AB's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Leonard Kruimer
Chairman Executive BoardMr. Leonard Kruimer has been the Chairman of the company since 2018. Prior to this, he served as a Member of the Board of BioInvent from 2016 to 2017. Previously, he served as the Chief Financial Officer and a board member at Crucell NV. Mr. Kruimer also held senior executive positions at GE Capital, Royal Boskalis, and Continental Can Inc.
Martin Welschof
Chief Executive Officer Senior ManagementMr. Martin Welschof has been the Chief Executive Officer of the company since 2018. Prior to this, he served as the Chief Executive Officer at Affitech and Opsona Therapeutics. Previously, he served as the Director of Technology at Axaron Bioscience from 1999 to 2002. Mr. Welschof also held board member positions at APIM Therapeutics AS and Nextera AS.
Stefan Ericsson
Chief Financial Officer Senior ManagementMr. Stefan Ericsson has been the Chief Financial Officer of the company since 2016. Prior to this, he served as the Director of Business Control. Previously, he served as an Auditor at PricewaterhouseCoopers from 1990 to 1995.
Andres McAllister, Ph.D.
Chief Medical Officer Senior ManagementDr. Andres McAllister has been the Chief Medical Officer of the company since 2017. Prior to this, he served as the Chief Scientific Officer at Debiopharm. Previously, he held various senior positions at IDM and BioMerieux/Pierre Fabre.
Bjorn Frendeus
Chief Scientific Officer Senior ManagementMr. Bjorn Frendeus is the Chief Scientific Officer of the company. Prior to this, he served as the Acting Chief Executive Officer of the company.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer